How to overcome antibiotic overuse in COVID-19 patients?

How to overcome antibiotic overuse in COVID-19 patients? Antibiotic stewardship programs with B·R·A·H·M·S PCT

Speakers

Valerie Vaughn
Director of Hospital Medicine Research in the Division of General Internal Medicine
University of Utah, Salt Lake City, USA

Neil Powell
Consultant Antimicrobial Pharmacist
Royal Cornwall Hospitals NHS Trust, Truro, UK


Find Thermo Fisher Scientific on Social Media

 

Exhibit

Symposia

Workshops

Organiser

Sponsor



Procalcitonin (PCT) is a biomarker widely used to assess the risk of bacterial infection and to aid in antibiotic stewardship in patients with lower respiratory tract infections (LRTI) and sepsis.


Evolving evidence now demonstrates that PCT can also be a valuable tool in the current COVID-19 pandemic to aid in early identification of patients at low risk of bacterial co-infection on admission as well as assist in the detection of bacterial superinfection in hospitalized patients.


Dr. Valerie Vaughn (University of Utah, USA) and Dr. Neil Powell (Royal Cornwall Hospitals NHS Trust, UK) share the latest information and own experience on the role of Procalcitonin (PCT) in the management of these critical patients.


A Certificate of Attendance will be sent to participants.

Learning Objectives

  • Provide an overview on the risk of bacterial co-infection in COVID-19 patients and the challenge of avoiding antibiotic prescriptions overuse in these patients
  • Describe how PCT can differentiate between viral and bacterial respiratory tract infections and aid in antibiotic decision making in patients with lower respiratory tract infections
  • Review the unfolding data examining the utility of PCT in antibiotic stewardship in COVID-19 patients suspected of bacterial co-infection
  • Present and discuss clinical experience and clinical case reports related to PCT and COVID-19

Agenda


Bacterial coinfections as risk factor in COVID-19 patients - how does the pandemic impact antibiotic prescription?
Results from multicentric study on how a more rational use of antibiotics in COVID-19 patients could be achieved
Dr. Valerie Vaughn, University of Utah, USA


Procalcitonin as a tool for differential diagnosis of bacterial infection and antibiotic stewardship in LRTI
First experience on its utility for antibiotic stewardship in COVID-19 patients
Dr. Neil Powell, Royal Cornwall Hospitals NHS Trust, UK


Q&A

Registration available online here




More events

Critical Care Canada Forum 2021

Mon, 6 Dec 2021 - Wed, 8 Dec 2021

State of the Art 2021

Mon, 6 Dec 2021 - Wed, 8 Dec 2021

Euroanaesthesia 2021

Fri, 17 Dec 2021 - Sun, 19 Dec 2021

ASA ADVANCE 2022

Fri, 28 Jan 2022 - Sun, 30 Jan 2022

Dallas, Dallas
Texas
 The Big Sick TBS22

Wed, 9 Feb 2022 - Fri, 11 Feb 2022


Bodmenstrasse 12
Zermatt, Wallis 3920
Switzerland
ResusNL 2022 – Breathe

Tue, 8 Mar 2022 - Wed, 9 Mar 2022


Otto Reuchlinweg 996 3072 MD
Rotterdam
Netherlands
41st ISICEM INTERNATIONAL SYMPOSIUM ON INTENSIVE CARE & EMERGENCY MEDICINE

Tue, 22 Mar 2022 - Fri, 25 Mar 2022


Mont des Arts
Brussels, Brussels 1000
Belgium
32nd ECCMID 2022

Sat, 23 Apr 2022 - Tue, 26 Apr 2022


Rossio dos Olivais
Lisbon 1990-231

Related articles